$FULC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Fulcrum Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Fulcrum Therapeutics, Inc.. Get notifications about new insider transactions in Fulcrum Therapeutics, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 02 2021 | FULC | Fulcrum Therapeuti ... | Stuart Bryan | See Remarks | Option Exercise | A | 11.78 | 350,000 | 4,123,000 | 350,000 | |
| Mar 17 2021 | FULC | Fulcrum Therapeuti ... | Gould Robert J | See Remarks | Sell | S | 12.43 | 789 | 9,806 | 506,630 | 507.4 K to 506.6 K (-0.16 %) |
| Mar 17 2021 | FULC | Fulcrum Therapeuti ... | Gould Robert J | See Remarks | Sell | S | 12.13 | 9,211 | 111,773 | 507,419 | 516.6 K to 507.4 K (-1.78 %) |
| Feb 24 2021 | FULC | Fulcrum Therapeuti ... | Thomson Peter G. | VP Finance & Accoun ... | Option Exercise | M | 7.84 | 5,000 | 39,200 | 50,471 | |
| Feb 24 2021 | FULC | Fulcrum Therapeuti ... | Thomson Peter G. | VP Finance & Accoun ... | Sell | S | 14.72 | 5,000 | 73,582 | 15,212 | 20.2 K to 15.2 K (-24.74 %) |
| Feb 24 2021 | FULC | Fulcrum Therapeuti ... | Thomson Peter G. | VP Finance & Accoun ... | Buy | M | 7.84 | 5,000 | 39,200 | 20,212 | 15.2 K to 20.2 K (+32.87 %) |
| Feb 04 2021 | FULC | Fulcrum Therapeuti ... | Gould Robert J | See Remarks | Option Exercise | A | 11.33 | 269,390 | 3,052,189 | 269,390 | |
| Jan 25 2021 | FULC | Fulcrum Therapeuti ... | Thomson Peter G. | VP Finance & Accoun ... | Sell | S | 14.00 | 6,607 | 92,498 | 15,212 | 21.8 K to 15.2 K (-30.28 %) |
| Dec 07 2020 | FULC | Fulcrum Therapeuti ... | Ezekowitz Alan | Director | Option Exercise | A | 11.82 | 15,000 | 177,300 | 15,000 | |
| Sep 14 2020 | FULC | Fulcrum Therapeuti ... | Wallace Owen B. | Chief Scientific Of ... | Option Exercise | M | 7.84 | 6,350 | 49,784 | 75,592 | |
| Sep 14 2020 | FULC | Fulcrum Therapeuti ... | Wallace Owen B. | Chief Scientific Of ... | Buy | M | 7.84 | 6,350 | 49,784 | 133,438 | 127.1 K to 133.4 K (+5.00 %) |
| Jul 09 2020 | FULC | Fulcrum Therapeuti ... | Wallace Owen B. | Chief Scientific Of ... | Option Exercise | M | 7.84 | 2,951 | 23,136 | 81,942 | |
| Jul 09 2020 | FULC | Fulcrum Therapeuti ... | Wallace Owen B. | Chief Scientific Of ... | Sell | S | 20.00 | 2,951 | 59,020 | 127,088 | 130 K to 127.1 K (-2.27 %) |
| Jul 09 2020 | FULC | Fulcrum Therapeuti ... | Wallace Owen B. | Chief Scientific Of ... | Buy | M | 7.84 | 2,951 | 23,136 | 130,039 | 127.1 K to 130 K (+2.32 %) |
| Jul 09 2020 | FULC | Fulcrum Therapeuti ... | Gould Robert J | See Remarks | Sell | S | 20.00 | 2,500 | 50,000 | 534,845 | 537.3 K to 534.8 K (-0.47 %) |
| Jul 01 2020 | FULC | Fulcrum Therapeuti ... | Wallace Owen B. | Chief Scientific Of ... | Option Exercise | M | 7.84 | 141 | 1,105 | 84,893 | |
| Jul 01 2020 | FULC | Fulcrum Therapeuti ... | Wallace Owen B. | Chief Scientific Of ... | Sell | S | 20.00 | 141 | 2,820 | 127,088 | 127.2 K to 127.1 K (-0.11 %) |
| Jul 01 2020 | FULC | Fulcrum Therapeuti ... | Wallace Owen B. | Chief Scientific Of ... | Buy | M | 7.84 | 141 | 1,105 | 127,229 | 127.1 K to 127.2 K (+0.11 %) |
| Jun 26 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Option Exercise | M | 4.83 | 1,459 | 7,047 | 12,277 | |
| Jun 26 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Sell | S | 22.00 | 1,459 | 32,098 | 66,785 | 68.2 K to 66.8 K (-2.14 %) |
| Jun 26 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Buy | M | 4.83 | 1,459 | 7,047 | 68,244 | 66.8 K to 68.2 K (+2.18 %) |
| Jun 26 2020 | FULC | Fulcrum Therapeuti ... | Gould Robert J | See Remarks | Sell | S | 20.80 | 2,500 | 51,992 | 537,345 | 539.8 K to 537.3 K (-0.46 %) |
| Jun 15 2020 | FULC | Fulcrum Therapeuti ... | LEVIN MARK J | Director | Option Exercise | A | 17.63 | 9,285 | 163,695 | 9,285 | |
| Jun 15 2020 | FULC | Fulcrum Therapeuti ... | GERAGHTY JAMES A | Director | Option Exercise | A | 17.63 | 9,285 | 163,695 | 9,285 | |
| Jun 15 2020 | FULC | Fulcrum Therapeuti ... | Ezekowitz Alan | Director | Option Exercise | A | 17.63 | 9,285 | 163,695 | 9,285 | |
| Jun 12 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Option Exercise | M | 4.83 | 401 | 1,937 | 13,736 | |
| Jun 12 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Sell | S | 22.00 | 401 | 8,822 | 66,785 | 67.2 K to 66.8 K (-0.60 %) |
| Jun 12 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Buy | M | 4.83 | 401 | 1,937 | 67,186 | 66.8 K to 67.2 K (+0.60 %) |
| Jun 10 2020 | FULC | Fulcrum Therapeuti ... | Gould Robert J | See Remarks | Sell | S | 20.00 | 156 | 3,120 | 539,845 | 540 K to 539.8 K (-0.03 %) |
| Jun 09 2020 | FULC | Fulcrum Therapeuti ... | Gould Robert J | See Remarks | Sell | S | 20.17 | 3,433 | 69,251 | 540,001 | 543.4 K to 540 K (-0.63 %) |
| Jun 08 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Option Exercise | M | 4.83 | 451 | 2,178 | 14,137 | |
| Jun 08 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Option Exercise | M | 4.83 | 226 | 1,092 | 14,588 | |
| Jun 08 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Sell | S | 20.18 | 451 | 9,101 | 66,785 | 67.2 K to 66.8 K (-0.67 %) |
| Jun 08 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Buy | M | 4.83 | 451 | 2,178 | 67,236 | 66.8 K to 67.2 K (+0.68 %) |
| Jun 08 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Sell | S | 20.05 | 226 | 4,531 | 66,785 | 67 K to 66.8 K (-0.34 %) |
| Jun 08 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Buy | M | 4.83 | 226 | 1,092 | 67,011 | 66.8 K to 67 K (+0.34 %) |
| Jun 05 2020 | FULC | Fulcrum Therapeuti ... | Gould Robert J | See Remarks | Sell | S | 20.04 | 1,300 | 26,058 | 543,434 | 544.7 K to 543.4 K (-0.24 %) |
| Jun 05 2020 | FULC | Fulcrum Therapeuti ... | Gould Robert J | See Remarks | Sell | S | 20.13 | 1,500 | 30,192 | 544,734 | 546.2 K to 544.7 K (-0.27 %) |
| Jun 04 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Option Exercise | M | 4.83 | 338 | 1,633 | 14,814 | |
| Jun 04 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Option Exercise | M | 4.83 | 45 | 217 | 15,152 | |
| Jun 04 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Sell | S | 20.18 | 338 | 6,820 | 66,785 | 67.1 K to 66.8 K (-0.50 %) |
| Jun 04 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Buy | M | 4.83 | 338 | 1,633 | 67,123 | 66.8 K to 67.1 K (+0.51 %) |
| Jun 04 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Sell | S | 20.00 | 45 | 900 | 66,785 | 66.8 K to 66.8 K (-0.07 %) |
| Jun 04 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Buy | M | 4.83 | 45 | 217 | 66,830 | 66.8 K to 66.8 K (+0.07 %) |
| Jun 03 2020 | FULC | Fulcrum Therapeuti ... | Gould Robert J | See Remarks | Sell | S | 20.00 | 2,797 | 55,940 | 546,234 | 549 K to 546.2 K (-0.51 %) |
| Jun 03 2020 | FULC | Fulcrum Therapeuti ... | Gould Robert J | See Remarks | Sell | S | 20.00 | 5 | 100 | 549,031 | 549 K to 549 K (0.00 %) |
| Jun 01 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Option Exercise | M | 4.83 | 200 | 966 | 15,197 | |
| Jun 01 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Option Exercise | M | 4.83 | 600 | 2,898 | 15,397 | |
| Jun 01 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Sell | S | 20.04 | 200 | 4,007 | 66,785 | 67 K to 66.8 K (-0.30 %) |
| Jun 01 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Buy | M | 4.83 | 200 | 966 | 66,985 | 66.8 K to 67 K (+0.30 %) |
| Jun 01 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Sell | S | 20.00 | 600 | 12,000 | 66,785 | 67.4 K to 66.8 K (-0.89 %) |
| Jun 01 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Buy | M | 4.83 | 600 | 2,898 | 67,385 | 66.8 K to 67.4 K (+0.90 %) |
| Jun 01 2020 | FULC | Fulcrum Therapeuti ... | Gould Robert J | See Remarks | Sell | S | 20.08 | 1,390 | 27,911 | 549,036 | 550.4 K to 549 K (-0.25 %) |
| Jun 01 2020 | FULC | Fulcrum Therapeuti ... | Gould Robert J | See Remarks | Sell | S | 20.01 | 1,919 | 38,391 | 550,426 | 552.3 K to 550.4 K (-0.35 %) |
| Jun 01 2020 | FULC | Fulcrum Therapeuti ... | Wallace Owen B. | Chief Scientific Of ... | Option Exercise | M | 7.84 | 2,232 | 17,499 | 85,034 | |
| Jun 01 2020 | FULC | Fulcrum Therapeuti ... | Wallace Owen B. | Chief Scientific Of ... | Sell | S | 20.00 | 2,232 | 44,640 | 127,088 | 129.3 K to 127.1 K (-1.73 %) |
| Jun 01 2020 | FULC | Fulcrum Therapeuti ... | Wallace Owen B. | Chief Scientific Of ... | Buy | M | 7.84 | 2,232 | 17,499 | 129,320 | 127.1 K to 129.3 K (+1.76 %) |
| May 28 2020 | FULC | Fulcrum Therapeuti ... | Wallace Owen B. | Chief Scientific Of ... | Option Exercise | M | 7.84 | 412 | 3,230 | 87,714 | |
| May 28 2020 | FULC | Fulcrum Therapeuti ... | Wallace Owen B. | Chief Scientific Of ... | Sell | S | 20.00 | 412 | 8,240 | 127,088 | 127.5 K to 127.1 K (-0.32 %) |
| May 28 2020 | FULC | Fulcrum Therapeuti ... | Wallace Owen B. | Chief Scientific Of ... | Buy | M | 7.84 | 412 | 3,230 | 127,500 | 127.1 K to 127.5 K (+0.32 %) |
| May 28 2020 | FULC | Fulcrum Therapeuti ... | Gould Robert J | See Remarks | Sell | S | 20.00 | 2,500 | 50,000 | 552,345 | 554.8 K to 552.3 K (-0.45 %) |
| May 12 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Option Exercise | M | 4.83 | 1,860 | 8,984 | 15,997 | |
| May 12 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Sell | S | 18.00 | 1,860 | 33,480 | 66,785 | 68.6 K to 66.8 K (-2.71 %) |
| May 12 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Buy | M | 4.83 | 1,860 | 8,984 | 68,645 | 66.8 K to 68.6 K (+2.79 %) |
| May 12 2020 | FULC | Fulcrum Therapeuti ... | Thomson Peter G. | VP Finance & Accoun ... | Sell | S | 16.00 | 7,500 | 120,000 | 21,071 | 28.6 K to 21.1 K (-26.25 %) |
| Mar 02 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Sell | S | 18.13 | 315 | 5,710 | 66,785 | 67.1 K to 66.8 K (-0.47 %) |
| Mar 02 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Sell | S | 17.26 | 1,828 | 31,545 | 67,100 | 68.9 K to 67.1 K (-2.65 %) |
| Feb 26 2020 | FULC | Fulcrum Therapeuti ... | Thomson Peter G. | VP Finance & Accoun ... | Sell | S | 18.61 | 250 | 4,653 | 28,571 | 28.8 K to 28.6 K (-0.87 %) |
| Feb 26 2020 | FULC | Fulcrum Therapeuti ... | Thomson Peter G. | VP Finance & Accoun ... | Sell | S | 17.43 | 2,102 | 36,643 | 28,821 | 30.9 K to 28.8 K (-6.80 %) |
| Feb 26 2020 | FULC | Fulcrum Therapeuti ... | Thomson Peter G. | VP Finance & Accoun ... | Sell | S | 16.18 | 2,648 | 42,857 | 30,923 | 33.6 K to 30.9 K (-7.89 %) |
| Feb 20 2020 | FULC | Fulcrum Therapeuti ... | Gould Robert J | See Remarks | Sell | S | 20.00 | 2,500 | 50,000 | 554,845 | 557.3 K to 554.8 K (-0.45 %) |
| Feb 20 2020 | FULC | Fulcrum Therapeuti ... | Wallace Owen B. | Chief Scientific Of ... | Option Exercise | M | 7.84 | 6,088 | 47,730 | 88,126 | |
| Feb 20 2020 | FULC | Fulcrum Therapeuti ... | Wallace Owen B. | Chief Scientific Of ... | Sell | S | 20.00 | 6,088 | 121,760 | 127,088 | 133.2 K to 127.1 K (-4.57 %) |
| Feb 20 2020 | FULC | Fulcrum Therapeuti ... | Wallace Owen B. | Chief Scientific Of ... | Buy | M | 7.84 | 6,088 | 47,730 | 133,176 | 127.1 K to 133.2 K (+4.79 %) |
| Feb 05 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Sell | S | 17.33 | 2,143 | 37,142 | 68,928 | 71.1 K to 68.9 K (-3.02 %) |
| Jan 27 2020 | FULC | Fulcrum Therapeuti ... | Stuart Bryan | Chief Operating Off ... | Option Exercise | A | 16.87 | 105,000 | 1,771,350 | 105,000 | |
| Jan 27 2020 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | SVP Clinical Develo ... | Option Exercise | A | 16.87 | 55,440 | 935,273 | 55,440 | |
| Jan 27 2020 | FULC | Fulcrum Therapeuti ... | Thomson Peter G. | VP Finance & Accoun ... | Option Exercise | A | 16.87 | 33,100 | 558,397 | 33,100 | |
| Jan 27 2020 | FULC | Fulcrum Therapeuti ... | Thomson Peter G. | VP Finance & Accoun ... | Sell | S | 18.05 | 262 | 4,730 | 33,571 | 33.8 K to 33.6 K (-0.77 %) |
| Jan 27 2020 | FULC | Fulcrum Therapeuti ... | Thomson Peter G. | VP Finance & Accoun ... | Sell | S | 17.17 | 4,738 | 81,372 | 33,833 | 38.6 K to 33.8 K (-12.28 %) |
| Jan 27 2020 | FULC | Fulcrum Therapeuti ... | Gould Robert J | President & CEO | Option Exercise | A | 16.87 | 200,000 | 3,374,000 | 200,000 | |
| Jan 27 2020 | FULC | Fulcrum Therapeuti ... | Wallace Owen B. | Chief Scientific Of ... | Option Exercise | A | 16.87 | 58,900 | 993,643 | 58,900 | |
| Jan 06 2020 | FULC | Fulcrum Therapeuti ... | Dorton Katina | Director | Option Exercise | A | 15.86 | 18,571 | 294,536 | 18,571 | |
| Jul 24 2019 | FULC | Fulcrum Therapeuti ... | GLAXOSMITHKLINE PLC | Option Exercise | C | 0.00 | 12,500,000 | 0 | 0 | ||
| Jul 24 2019 | FULC | Fulcrum Therapeuti ... | GLAXOSMITHKLINE PLC | Buy | C | 0.00 | 1,785,714 | 0 | 1,785,714 | 0 to 1.8 M | |
| Jul 23 2019 | FULC | Fulcrum Therapeuti ... | Sanofi | 10% Owner | Option Exercise | C | 0.00 | 3,250,000 | 0 | 0 | |
| Jul 23 2019 | FULC | Fulcrum Therapeuti ... | Sanofi | 10% Owner | Buy | P | 16.00 | 93,750 | 1,500,000 | 558,035 | 464.3 K to 558 K (+20.19 %) |
| Jul 23 2019 | FULC | Fulcrum Therapeuti ... | Sanofi | 10% Owner | Buy | C | 0.00 | 464,285 | 0 | 464,285 | 0 to 464.3 K |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | Third Rock Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 15,833,333 | 0 | 0 | |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | Third Rock Ventures IV, L.P. | 10% Owner | Buy | P | 16.00 | 81,250 | 1,300,000 | 2,343,154 | 2.3 M to 2.3 M (+3.59 %) |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | Third Rock Ventures IV, L.P. | 10% Owner | Buy | C | 0.00 | 2,261,904 | 0 | 2,261,904 | 0 to 2.3 M |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | Third Rock Ventures III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 39,166,667 | 0 | 0 | |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | Third Rock Ventures III, L.P. | 10% Owner | Buy | P | 16.00 | 81,250 | 1,300,000 | 5,962,202 | 5.9 M to 6 M (+1.38 %) |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | Third Rock Ventures III, L.P. | 10% Owner | Buy | C | 0.00 | 5,595,238 | 0 | 5,880,952 | 285.7 K to 5.9 M (+1,958.34 %) |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | 6 Dimensions Capital, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,087,500 | 0 | 0 | |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | 6 Dimensions Capital, L.P. | 10% Owner | Buy | P | 16.00 | 118,750 | 1,900,000 | 559,821 | 441.1 K to 559.8 K (+26.92 %) |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | 6 Dimensions Capital, L.P. | 10% Owner | Buy | C | 0.00 | 441,071 | 0 | 441,071 | 0 to 441.1 K |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | Casdin Capital, LLC | 10% Owner | Option Exercise | C | 0.00 | 3,250,000 | 0 | 0 | |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | Casdin Capital, LLC | 10% Owner | Buy | P | 14.50 | 5,000 | 72,499 | 604,285 | 599.3 K to 604.3 K (+0.83 %) |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | Casdin Capital, LLC | 10% Owner | Buy | P | 14.50 | 10,000 | 144,996 | 599,285 | 589.3 K to 599.3 K (+1.70 %) |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | Casdin Capital, LLC | 10% Owner | Buy | P | 16.00 | 125,000 | 2,000,000 | 589,285 | 464.3 K to 589.3 K (+26.92 %) |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | Casdin Capital, LLC | 10% Owner | Buy | C | 0.00 | 464,285 | 0 | 464,285 | 0 to 464.3 K |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | LEVIN MARK J | Director | Option Exercise | C | 0.00 | 39,166,667 | 0 | 0 | |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | LEVIN MARK J | Director | Buy | P | 16.00 | 81,250 | 1,300,000 | 5,962,202 | 5.9 M to 6 M (+1.38 %) |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | LEVIN MARK J | Director | Buy | C | 0.00 | 5,595,238 | 0 | 5,880,952 | 285.7 K to 5.9 M (+1,958.34 %) |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | Section 32 Fund 2, LP | 10% Owner | Option Exercise | C | 0.00 | 3,250,000 | 0 | 0 | |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | Section 32 Fund 2, LP | 10% Owner | Buy | C | 0.00 | 464,285 | 0 | 464,285 | 0 to 464.3 K |
| Jul 18 2019 | FULC | Fulcrum Therapeuti ... | Wallace Owen B. | Chief Scientific Of ... | Option Exercise | A | 16.00 | 44,493 | 711,888 | 44,493 | |
| Jul 18 2019 | FULC | Fulcrum Therapeuti ... | Collins James J. | Director | Option Exercise | A | 16.00 | 5,714 | 91,424 | 5,714 | |
| Jul 18 2019 | FULC | Fulcrum Therapeuti ... | GERAGHTY JAMES A | Director | Option Exercise | A | 16.00 | 9,285 | 148,560 | 9,285 | |
| Jul 18 2019 | FULC | Fulcrum Therapeuti ... | Ezekowitz Alan | Director | Option Exercise | A | 16.00 | 5,714 | 91,424 | 5,714 | |
| Jul 18 2019 | FULC | Fulcrum Therapeuti ... | Haviland Kate | Director | Option Exercise | A | 16.00 | 9,285 | 148,560 | 9,285 | |
| Jul 18 2019 | FULC | Fulcrum Therapeuti ... | Gould Robert J | See Remarks | Option Exercise | A | 16.00 | 107,142 | 1,714,272 | 107,142 | |
| Jul 18 2019 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | See Remarks | Option Exercise | A | 16.00 | 12,784 | 204,544 | 12,784 | |
| Jul 18 2019 | FULC | Fulcrum Therapeuti ... | Stuart Bryan | Chief Operating Off ... | Option Exercise | A | 16.00 | 28,571 | 457,136 | 28,571 | |
| Jul 18 2019 | FULC | Fulcrum Therapeuti ... | Thomson Peter G. | See Remarks | Option Exercise | A | 16.00 | 7,078 | 113,248 | 7,078 |
Page: 1